Article
LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
2024-11-20
Abstract excerpt
<title>Abstract</title> <p>Background TP53 mutations are linked to aggressive progression and chemoresistance in gastric cancer (GC). Frameshift mutation is the second most common mutation type of TP53. However, the consequences of this mutation type in GC were not well understood, and targeted therapies for cancer patients harboring frameshift mutations were also not established. Histone methylation significant...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eba2258b-0a92-5129-b728-40935395888d
- DOI
- 10.21203/rs.3.rs-5315632/v1
